Sanner Group Appoints Stefan Verheyden as CEO to Drive MedTech Expansion
Sanner Group, a leading provider of packaging solutions, has appointed Stefan Verheyden as its new CEO. Verheyden brings over three decades of experience in the pharma and biopharma industry to the role.
Verheyden's extensive career includes serving as global VP pharma and biopharma injectables at Gerresheimer. He aims to build on Sanner's legacy in pharmaceutical and nutraceutical packaging while accelerating expansion into the MedTech Contract Development and Manufacturing Organisation (CDMO) space.
Sanner Group's recent acquisitions under GHO Capital's majority ownership reflect this strategy. In January 2024, the company acquired a UK-based medical device design and development specialist. Then, in September 2024, Sanner Group acquired Gilero, a medical device design, development, and contract manufacturer.
Stefan Verheyden's appointment as CEO of Sanner Group signals a commitment to growth and expansion in the MedTech CDMO sector. With his extensive industry experience and the company's recent strategic acquisitions, Sanner Group is poised to strengthen its position in both pharmaceutical packaging and medical device contract manufacturing.
